857.99M
Market cap
81.08x
Current P/E
64.10x
Forward P/E

About

Health care
Sector
Healthcare - Information Services
Industry

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Similar securities

Based on sector and market capitalization

Report issue